Question

The following is a reason for an apparent lack of benefit from a screening program: a. The usual diagnosis of disease happens very late in the disease progression. b. The preclinical phase of disease is very long. c. The clinical phase of disease is long and usually ends with the death of the patient. d. The current therapies are very effective when administered in the preclinical phase of disease. e. The available treatments are not effective even when administered early in the disease progression.

Name: the following is a reason for an apparent lack of benefit from a screening program a the usual diagnosis of disease happens very late in the disease progression b the preclinical phase of di 12375
Uploaded: 2023-09-06T08:37:02-08:00
Duration: 4 min
Channel: Adi S
Description: the following is a reason for an apparent lack of benefit from a screening program a the usual diagnosis of disease happens very late in the disease progression b the preclinical phase of di 12375

          The following is a reason for an apparent lack of benefit from a
screening program:
a.
The usual diagnosis of disease happens very late in the disease
progression.
b.
The preclinical phase of disease is very long.
c.
The clinical phase of disease is long and usually ends with the
death of the patient.
d.
The current therapies are very effective when administered in
the preclinical phase of disease.
e.
The available treatments are not effective even when
administered early in the disease progression.

Added by Rebecca S.

Biology for AP Courses

Julianne Zedalis, John Eggebrecht

Instant Answer

Solved by Expert Adi S

09/06/2023

Step 1

If the usual diagnosis of disease happens very late in the disease progression, then a screening program that detects the disease earlier could potentially be beneficial. So, this is not a reason for an apparent lack of benefit. b. If the preclinical phase of Show more…

Show all steps

Thanks for your feedback!

The following is a reason for an apparent lack of benefit from a screening program: a. The usual diagnosis of disease happens very late in the disease progression. b. The preclinical phase of disease is very long. c. The clinical phase of disease is long and usually ends with the death of the patient. d. The current therapies are very effective when administered in the preclinical phase of disease. e. The available treatments are not effective even when administered early in the disease progression.